Long-term outcomes in a cohort of patients with juvenile idiopathic arthritis: serological phenotypes and disease activity in adulthood

  • Marta Priora | marta.priora@gmail.com Division of Rheumatology, University Hospital Città della Salute e della Scienza, Turin, Italy. https://orcid.org/0000-0002-9194-9179
  • Tilde Manetta Division of Laboratory Medicine, University Hospital Città della Salute e della Scienza, Turin, Italy. https://orcid.org/0000-0001-5584-8883
  • Simone Parisi Division of Rheumatology, University Hospital Città della Salute e della Scienza, Turin, Italy.
  • Maria Chiara Ditto Division of Rheumatology, University Hospital Città della Salute e della Scienza, Turin, Italy. https://orcid.org/0000-0001-5025-287X
  • Angela Laganà Division of Rheumatology, University Hospital Città della Salute e della Scienza, Turin, Italy.
  • Clara Lisa Peroni Division of Rheumatology, University Hospital Città della Salute e della Scienza, Turin, Italy.
  • Giulio Mengozzi Division of Laboratory Medicine, University Hospital Città della Salute e della Scienza, Turin, Italy. https://orcid.org/0000-0003-0431-8369
  • Enrico Fusaro Division of Rheumatology, University Hospital Città della Salute e della Scienza, Turin, Italy. https://orcid.org/0000-0001-9888-2563

Abstract

In a scenario characterised by diagnostic and therapeutic improvements, an increasing number of juvenile idiopathic arthritis (JIA) patients require ongoing care into adulthood. Deepening the long-term study on JIA is fundamental in order to expand pathogenic knowledge, optimize treatment options and favour an active communication between paediatric and adult care-specialists. This study dealt with adult patients affected by JIA. The main objectives were: i) to analyse the serological profile to examine possible seroconversions in adults; ii) to evaluate the association between antibodies and disease activity; iii) to investigate the correlation between antibodies, diagnostic subgroups and disease activity. Sixty-eight patients were selected. A positive rheumatoidfactor and anti-citrullinated-peptides-antibodies tests were found both at diagnosis and in adulthood (P<0.05). Their association with the polyarticular subgroup persisted in the long term (P<0.05) and they associated with a higher disease activity in adulthood assessed with both JADAS27 and SDAI. At diagnosis, 45.6% of patients were ANA positive, while only 13.2% stayed positive in adulthood (P<0.05). These results may highlight the need to verify in adulthood the presence of ANA in those patients with JIA with ANA positivity at diagnosis.

Downloads

Download data is not yet available.
Published
2019-12-20
Section
Original Articles
Keywords:
Adulthood, juvenile idiopathic arthritis, long-term outcome, transition of care.
Statistics
Abstract views: 181

PDF: 56
Share it

PlumX Metrics

PlumX Metrics provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.

How to Cite
Priora, M., Manetta, T., Parisi, S., Ditto, M. C., Laganà, A., Peroni, C. L., Mengozzi, G., & Fusaro, E. (2019). Long-term outcomes in a cohort of patients with juvenile idiopathic arthritis: serological phenotypes and disease activity in adulthood. Beyond Rheumatology, 1(2), 63-67. https://doi.org/10.4081/br.2019.25